Variant report

Variant	esv3338088
Chromosome Location	chr9:101469131-101473529
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr9:101468754-101469148	K562	blood:	n/a	n/a
2	BACH1	chr9:101471747-101472017	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr9:101469493-101470319	H1-hESC	embryonic stem cell:	n/a	n/a
4	BHLHE40	chr9:101469630-101469698	K562	blood:	n/a	n/a
5	BRCA1	chr9:101469537-101469587	HepG2	liver:	n/a	n/a
6	CBX3	chr9:101469451-101469839	K562	blood:	n/a	n/a
7	CBX3	chr9:101472654-101472994	K562	blood:	n/a	n/a
8	CCNT2	chr9:101471103-101471297	K562	blood:	n/a	n/a
9	CCNT2	chr9:101469615-101470132	K562	blood:	n/a	n/a
10	CEBPB	chr9:101472349-101472812	IMR90	lung:	n/a	n/a
11	CEBPB	chr9:101472391-101472475	H1-hESC	embryonic stem cell:	n/a	n/a
12	CEBPB	chr9:101468879-101469156	K562	blood:	n/a	n/a
13	CEBPB	chr9:101468841-101469151	K562	blood:	n/a	n/a
14	CEBPB	chr9:101468825-101469347	IMR90	lung:	n/a	n/a
15	CEBPB	chr9:101472312-101472549	HepG2	liver:	n/a	n/a
16	CEBPB	chr9:101472340-101472637	K562	blood:	n/a	n/a
17	CEBPB	chr9:101472320-101472550	A549	lung:	n/a	n/a
18	CHD1	chr9:101468481-101470222	IMR90	lung:	n/a	n/a
19	CHD1	chr9:101469653-101469816	H1-hESC	embryonic stem cell:	n/a	n/a
20	CHD2	chr9:101469451-101469720	H1-hESC	embryonic stem cell:	n/a	n/a
21	CREB1	chr9:101469614-101469834	A549	lung:	n/a	n/a
22	CREB1	chr9:101469457-101469842	H1-hESC	embryonic stem cell:	n/a	n/a
23	CTBP2	chr9:101469139-101470244	H1-hESC	embryonic stem cell:	n/a	n/a
24	CTBP2	chr9:101471646-101472175	H1-hESC	embryonic stem cell:	n/a	n/a
25	CTCF	chr9:101469491-101469709	T-47D	breast:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
26	CTCF	chr9:101471980-101472130	K562	blood:	n/a	chr9:101472044-101472062 chr9:101472046-101472059 chr9:101472039-101472060
27	CTCF	chr9:101471900-101472050	BE2_C	brain:	n/a	chr9:101471978-101471991
28	CTCF	chr9:101469580-101469730	HBMEC	blood vessel:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
29	CTCF	chr9:101471880-101472030	HEK293	kidney:	n/a	chr9:101471978-101471991
30	CTCF	chr9:101469600-101469750	GM12870	blood:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
31	CTCF	chr9:101469580-101469730	AG10803	skin:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
32	CTCF	chr9:101469530-101469762	GM19240	blood:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
33	CTCF	chr9:101471880-101472275	K562	blood:	n/a	chr9:101472044-101472062 chr9:101472046-101472059 chr9:101472039-101472060 chr9:101471978-101471991
34	CTCF	chr9:101472040-101472190	HPAF	blood vessel:	n/a	chr9:101472044-101472062 chr9:101472046-101472059
35	CTCF	chr9:101469580-101469730	AG04450	lung:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
36	CTCF	chr9:101471980-101472107	Fibrobl	skin:	n/a	chr9:101472044-101472062 chr9:101472046-101472059 chr9:101472039-101472060
37	CTCF	chr9:101469600-101469750	HMEC	breast:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
38	CTCF	chr9:101469600-101469750	HCT-116	colon:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
39	CTCF	chr9:101469580-101469730	HVMF	connective:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
40	CTCF	chr9:101469620-101469770	HMEC	breast:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
41	CTCF	chr9:101469560-101469710	HRE	kidney:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
42	CTCF	chr9:101471940-101472090	WERI-Rb-1	eye:	n/a	chr9:101472044-101472062 chr9:101472046-101472059 chr9:101472039-101472060 chr9:101471978-101471991
43	CTCF	chr9:101469580-101469730	HepG2	liver:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
44	CTCF	chr9:101469560-101469710	HFF	foreskin:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
45	CTCF	chr9:101469450-101469950	K562	blood:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
46	CTCF	chr9:101469600-101469750	HRPEpiC	eye:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
47	CTCF	chr9:101469600-101469750	WI-38	lung:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
48	CTCF	chr9:101469479-101469722	A549	lung:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658
49	CTCF	chr9:101469500-101469650	GM12864	blood:	n/a	n/a
50	CTCF	chr9:101469540-101469690	HAc	cerebellar:	n/a	chr9:101469635-101469656 chr9:101469642-101469655 chr9:101469640-101469658

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:101471553-101471603	HUVEC	blood vessel:	n/a
2	chr9:101470004-101470054	IMR90	lung:	fetal
3	chr9:101470884-101470934	HNPCEpiC	eye:	n/a
4	chr9:101471553-101471603	HUVEC	blood vessel:	n/a
5	chr9:101470004-101470054	IMR90	lung:	fetal
6	chr9:101470884-101470934	HNPCEpiC	eye:	n/a
7	chr9:101469285-101469335	NB4	blood:	n/a
8	chr9:101469203-101469253	NB4	blood:	n/a
9	chr9:101470884-101470934	NB4	blood:	n/a
10	chr9:101471921-101471971	GM12891	blood:	n/a
11	chr9:101471921-101471971	BJ	skin:	n/a
12	chr9:101469285-101469335	GM12891	blood:	n/a
13	chr9:101469203-101469253	SK-N-MC	brain:	n/a
14	chr9:101471553-101471603	PFSK-1	brain:	n/a
15	chr9:101472149-101472199	H1-hESC	embryonic stem cell:	embryo
16	chr9:101471986-101472036	HRCEpiC	kidney:	n/a
17	chr9:101470796-101470846	HCM	heart:	n/a
18	chr9:101469285-101469335	U87	brain:	n/a
19	chr9:101470346-101470396	HRCEpiC	kidney:	n/a
20	chr9:101471986-101472036	HPAEpiC	pulmonary alveolar:	n/a
21	chr9:101470004-101470054	A549	lung:	n/a
22	chr9:101469711-101469761	HCM	heart:	n/a
23	chr9:101471921-101471971	HCPEpiC	choroid plexus:	n/a
24	chr9:101471986-101472036	GM12891	blood:	n/a
25	chr9:101469711-101469761	GM12878	blood:	n/a
26	chr9:101471921-101471971	IMR90	lung:	fetal
27	chr9:101469203-101469253	CMK	blood:	n/a
28	chr9:101471986-101472036	NB4	blood:	n/a
29	chr9:101470346-101470396	PANC-1	pancreas:	n/a
30	chr9:101470346-101470396	NH-A	brain:	n/a
31	chr9:101469203-101469253	Caco-2	colon:	n/a
32	chr9:101469915-101469965	AG04450	lung:	fetal
33	chr9:101471921-101471971	LNCaP	prostate:	n/a
34	chr9:101469285-101469335	Hepatocyte	liver:	n/a
35	chr9:101471553-101471603	K562	blood:	n/a
36	chr9:101470346-101470396	NB4	blood:	n/a
37	chr9:101472149-101472199	NB4	blood:	n/a
38	chr9:101470884-101470934	CMK	blood:	n/a
39	chr9:101471921-101471971	HIPEpiC	eye:	n/a
40	chr9:101469915-101469965	HUVEC	blood vessel:	n/a
41	chr9:101470346-101470396	HCT-116	colon:	n/a
42	chr9:101469915-101469965	AG10803	skin:	n/a
43	chr9:101471986-101472036	Caco-2	colon:	n/a
44	chr9:101470796-101470846	HL-60	blood:	n/a
45	chr9:101469915-101469965	K562	blood:	n/a
46	chr9:101469915-101469965	SK-N-MC	brain:	n/a
47	chr9:101470884-101470934	BJ	skin:	n/a
48	chr9:101470346-101470396	HNPCEpiC	eye:	n/a
49	chr9:101471921-101471971	AG10803	skin:	n/a
50	chr9:101470884-101470934	T-47D	breast:	n/a

No.	Distal block	Cell Line	Cell type
1	chr9:101390132..101392094-chr9:101471584..101473721,2	MCF-7	breast:
2	chr9:101469417..101470003-chr9:101537901..101538481,2	K562	blood:
3	chr9:100967716..100968659-chr9:101469208..101469729,2	K562	blood:
4	chr9:101298822..101299808-chr9:101469168..101470098,4	K562	blood:
5	chr9:101242548..101244258-chr9:101471901..101474101,2	MCF-7	breast:
6	chr9:101462868..101464769-chr9:101469228..101471376,2	MCF-7	breast:
7	chr9:100836437..100837120-chr9:101469356..101469982,2	K562	blood:
8	chr9:101455554..101459399-chr9:101467510..101471263,4	MCF-7	breast:

Variant related genes	Relation type
GABBR2	TF binding region
GABBR2	CpG island
ENSG00000095380	chromatin interactions

Extended variants
information (count: 134 )
Associated
traits (count: 76 )

Variant overlapped rSNPs/rCNVs (count:134 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs548479192	chr9:101469201-101469202	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs189510289	chr9:101469203-101469204	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs552326597	chr9:101469260-101469261	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs371279207	chr9:101469273-101469274	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs191297387	chr9:101469286-101469287	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs200412303	chr9:101469333-101469334	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs184452974	chr9:101469378-101469379	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs375976592	chr9:101469390-101469391	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs189775341	chr9:101469415-101469416	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs394488	chr9:101469448-101469449	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
11	rs557507706	chr9:101469464-101469465	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs76299135	chr9:101469501-101469502	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs577501242	chr9:101469580-101469581	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs540140996	chr9:101469586-101469587	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs553223283	chr9:101469611-101469612	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs571712221	chr9:101469674-101469675	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs540583517	chr9:101469687-101469688	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs377605182	chr9:101469737-101469738	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs554286317	chr9:101469794-101469795	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs415902	chr9:101469821-101469822	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs543282506	chr9:101469836-101469837	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs563484345	chr9:101469864-101469865	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs537997816	chr9:101469869-101469870	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs532176414	chr9:101469872-101469873	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs509747	chr9:101469934-101469935	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
26	rs559643963	chr9:101469969-101469970	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs528533332	chr9:101470005-101470006	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs140340504	chr9:101470016-101470017	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs34585686	chr9:101470088-101470089	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs373870173	chr9:101470117-101470118	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs507876	chr9:101470127-101470128	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
32	rs531017502	chr9:101470143-101470144	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs143225379	chr9:101470147-101470148	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs571046446	chr9:101470218-101470219	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs568222264	chr9:101470229-101470230	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs553262006	chr9:101470268-101470269	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs566815552	chr9:101470276-101470277	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs534364743	chr9:101470277-101470278	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs181426076	chr9:101470283-101470284	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs536652446	chr9:101470316-101470317	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs199584598	chr9:101470339-101470340	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs574484084	chr9:101470445-101470446	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs543522623	chr9:101470449-101470450	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs556755430	chr9:101470464-101470465	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs576975061	chr9:101470508-101470509	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs546007743	chr9:101470558-101470559	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs112410216	chr9:101470576-101470577	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs528370562	chr9:101470624-101470625	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs186943372	chr9:101470641-101470642	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs77213774	chr9:101470648-101470649	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:76)

Disease	PMID	Source
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
lymphocytic leukemia	21291569	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Leukemia	18688285	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute myeloid leukemia	21251322	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	17603634	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral cancer	21386901	CNVD
Bipolar disorder	18458673	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Gastric cancer	17908304	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Biliary cancer	19435499	CNVD
small cell lung cancer	20016488	CNVD
Intracranial aneurysm	16715129	CNVD
Cardiac fibroma	18329553	CNVD
Breast cancer	17133270	CNVD
Basal cell nevus syndrome	21572526	CNVD
Mental retardation	19951919	CNVD
Retinoblastoma	22278416	CNVD
9q22.3 microdeletion syndrome	22283845	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
overgrowth syndrome	16570072	CNVD
Neurodevelopmental disorder	22521361	CNVD
Nicotine dependence	17160897	CNVD
Mantle cell lymphoma	19029149	CNVD
Esophageal cancer	21851588	CNVD
Melanoma	17363583	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:386 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:101468600-101469200	Bivalent/Poised TSS	Brain Dorsolateral Prefrontal Cortex	brain
2	chr9:101468800-101469200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
3	chr9:101468800-101469400	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
4	chr9:101468800-101469600	Flanking Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
5	chr9:101468800-101469800	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
6	chr9:101468800-101469800	Active TSS	Brain Inferior Temporal Lobe	brain
7	chr9:101469000-101469200	Bivalent Enhancer	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr9:101469000-101469200	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
9	chr9:101469000-101469200	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
10	chr9:101469000-101469200	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
11	chr9:101469000-101469200	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
12	chr9:101469000-101469200	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
13	chr9:101469000-101469200	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
14	chr9:101469000-101469200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
15	chr9:101469000-101469200	Bivalent Enhancer	Liver	Liver
16	chr9:101469000-101469200	Bivalent/Poised TSS	Brain Angular Gyrus	brain
17	chr9:101469000-101469200	Flanking Bivalent TSS/Enh	Brain Anterior Caudate	brain
18	chr9:101469000-101469200	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
19	chr9:101469000-101469200	Flanking Bivalent TSS/Enh	Fetal Brain Male	brain
20	chr9:101469000-101469200	Flanking Bivalent TSS/Enh	Fetal Kidney	kidney
21	chr9:101469000-101469200	Flanking Bivalent TSS/Enh	Osteobl	bone
22	chr9:101469000-101469400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr9:101469000-101469400	Flanking Bivalent TSS/Enh	Ganglion Eminence derived primary cultured neurospheres	brain
24	chr9:101469000-101469400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
25	chr9:101469000-101469400	Flanking Bivalent TSS/Enh	Fetal Brain Female	brain
26	chr9:101469000-101469400	Bivalent Enhancer	Fetal Intestine Small	intestine
27	chr9:101469000-101469400	Enhancers	Pancreas	Pancrea
28	chr9:101469000-101469400	Bivalent Enhancer	NH-A	brain
29	chr9:101469000-101469600	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
30	chr9:101469000-101469600	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
31	chr9:101469000-101469800	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
32	chr9:101469000-101469800	Bivalent Enhancer	Fetal Stomach	stomach
33	chr9:101469000-101469800	Bivalent Enhancer	Ovary	ovary
34	chr9:101469000-101469800	Bivalent Enhancer	NHDF-Ad	bronchial
35	chr9:101469000-101470000	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain
36	chr9:101469000-101470000	Bivalent Enhancer	Spleen	Spleen
37	chr9:101469000-101470600	Flanking Active TSS	HUVEC	blood vessel
38	chr9:101469000-101470800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
39	chr9:101469000-101471000	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr9:101469000-101471000	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
41	chr9:101469000-101471800	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
42	chr9:101469200-101469400	Flanking Bivalent TSS/Enh	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
43	chr9:101469200-101469400	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
44	chr9:101469200-101469400	Flanking Bivalent TSS/Enh	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
45	chr9:101469200-101469400	Flanking Bivalent TSS/Enh	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
46	chr9:101469200-101469400	Bivalent Enhancer	Primary hematopoietic stem cells	blood
47	chr9:101469200-101469400	Flanking Bivalent TSS/Enh	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
48	chr9:101469200-101469400	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
49	chr9:101469200-101469400	Bivalent/Poised TSS	Brain Anterior Caudate	brain
50	chr9:101469200-101469400	Bivalent Enhancer	Fetal Brain Male	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links